Jeffrey Schelling, M.D., a professor in the Department of Physiology and Biophysics, has received a Scholar-Innovator award from the Harrington Discovery Institute to develop a novel drug to treat diabetic kidney disease.
Harrington Discovery Institute at University Hospitals Cleveland was established in 2012 to accelerate the development of new treatments to address major unmet needs in medicine and society. Harrington Scholar-Innovators are accomplished physician-scientists whose research demonstrates innovation, creativity and potential for clinical impact.
